In the News
Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
Time to dive into the forefront of Alzheimer’s disease research! Join us for an exclusive on-demand webinar featuring Dr. Rudolf Tanzi, renowned expert and co-discoverer of all three early-onset familial Alzheimer’s disease genes, John Dwyer, President of the Global Alzheimer’s Platform Foundation (GAP), and our CEO, Colin Hill.
Servier and Aitia Mobilize AI and Digital Twins to Treat Pancreatic Cancer
The French pharmaceutical group Servier and Aitia announced on May 17th a multi-year partnership agreement for the discovery and simulation of drugs in pancreatic cancer. It is based on the combination of Servier’s expertise in preclinical trials with Aitia’s technology, which is based on artificial intelligence and Gemini Digital Twins…
Colin Hill Weighs in on the Future of Drug Discovery on the Patients Rising Podcast
In this week’s episode of the Patients Rising podcast, Colin passionately shared his beliefs and vision for the future of medical research, highlighting the transformative potential of AI-powered clinical trials and the revolutionary power of Digital Twins…
Events
A Digital Boost for Pharmaceutical R&D: Join our CEO, Colin Hill at the Orion Day in Finland
Building a fast-lane to novel therapies: Aitia CEO Colin Hill at Orion Day on October 6 in Espoo, Finland.
Accelerating Drug Target Identification and Validation with AI and Digital Twins: Join our CBO, Joseph Donahue at BioTechX Europe 2023
Revolutionizing drug discovery and development with AI and Digital Twins: Join Aitia CBO, Joseph Donahue at BioTechX Europe 2023 in Basel.
CEO and Investor Roundtable Discussion: Join our CEO, Colin Hill at BioCentury East-West Pharma Summit 2023
Join Aitia’ CEO Colin Hill on the Roundtable discussion at East-West Pharma Summit to explore the future for Biotechs with industry experts Christine Aylward, Founding & Managing Partner, Magnetic Ventures, Nathalie Beslay, Co-Founder, NAAIA, and Alan Jiang, Director & Chief Strategy Officer, XtalPi on October 4 in Cambridge, MA.
Press Releases
Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer
Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced the appointment of Dr. Jean-Michel Gries as President & Chief Operating Officer.
Alzheimer’s Disease Mechanistic Pathways Discovered through Aitia’s Digital Twins and in silico Experiments in Causal AI to be Presented at AAIC 2023
Aitia, the leader in the application of Causal AI and Digital Twins to discover and develop new drugs, announced today that data from its Alzheimer’s Disease Digital Twins will be presented at the upcoming Alzheimer’s Association International Conference (AAIC).
Aitia Enters into Multi-Year AI-Driven Drug Discovery and Drug Simulation Collaboration with Servier for Pancreatic Cancer
Aitia, the leader in the development and application of Causal AI and “Digital Twins” to discover and develop new drugs, today announced a collaboration with Servier to create new Gemini Digital Twins to help in the fight against Pancreatic Cancer.